Just chit chat here Miljenko, no bioscience, so disregard if shareprice banter annoys you!
During recent market weakness SNAP had held up
well...ouperforming BBH for instance by 30% over
the last three months.
quote.yahoo.com
However, in the last few days, even as the Nasdaq
has had a strong showing, somebody has decided to
let a few shares of Synaptic go at cheaper prices,
and the shares have fallen from 6 3/8ths to 5 3/4.
Suppose Synaptic loses it's case agains MDS Panlabs,
or suppose Lampert decides to lighten up...or for
whatever reason SNAP goes back down to test the $4
area.... Would anybody be a buyer?
Still long SNAP, but one by one my handful of positions
in microcap biotechs have got whacked. I've increased
my cash position to about 77% in this sucky market,
so I'll weather further beatings okay. Still, I was
wondering. I'd hate to be wrong again. First CeNes,
then Genset, then Valentis got a little weak, and now
a seller appears in Synaptic. Is it any wonder I am
pretty much throwing in the towel, ha! |
